Literature DB >> 30774698

Factors affecting the concordance of radiologic and pathologic tumor size in breast carcinoma.

Ameer Hamza1, Sidrah Khawar1, Ramen Sakhi1, Ahmed Alrajjal1, Shelby Miller1, Warda Ibrar1, Jacob Edens1, Sajad Salehi1, Daniel Ockner1.   

Abstract

BACKGROUND: Radiologic assessment of tumor size is an integral part of the work-up for breast carcinoma. With improved radiologic equipment, surgical decision relies profoundly upon radiologic/clinical stage. We wanted to see the concordance between radiologic and pathologic tumor size to infer how accurate radiologic/clinical staging is.
MATERIALS AND METHODS: The surgical pathology and ultrasonography reports of patients with breast carcinoma were reviewed. Data were collected for 406 cases. Concordance was defined as a size difference within ±2 mm.
RESULTS: The difference between radiologic and pathologic tumor size was within ±2 mm in 40.4% cases. The mean radiologic size was 1.73 ± 1.06 cm. The mean pathologic size was 1.84 ± 1.24 cm. A paired t-test showed a significant mean difference between radiologic and pathologic measurements (0.12 ± 1.03 cm, p = 0.03). Despite the size difference, stage classification was the same in 59.9% of cases. Radiologic size overestimated stage in 14.5% of cases and underestimated stage in 25.6% of cases. The concordance rate was significantly higher for tumors ≤2 cm (pT1) (51.1%) as compared to those greater than 2 cm (≥pT2) (19.7%) (p < 0.0001). Significantly more lumpectomy specimens (47.5%) had concordance when compared to mastectomy specimens (29.8%) (p < 0.0001). Invasive ductal carcinoma had better concordance compared to other tumors (p = 0.02).
CONCLUSION: Mean pathologic tumor size was significantly different from mean radiologic tumor size. Concordance was in just over 40% of cases and the stage classification was the same in about 60% of cases only. Therefore, surgical decision of lumpectomy versus mastectomy based on radiologic tumor size may not always be accurate.

Entities:  

Keywords:  Breast carcinoma; breast ultrasound; concordance; pathologic staging; tumor size

Year:  2018        PMID: 30774698      PMCID: PMC6362536          DOI: 10.1177/1742271X18804278

Source DB:  PubMed          Journal:  Ultrasound        ISSN: 1742-271X


  50 in total

1.  Correlating sonography, mammography, and pathology in the assessment of breast cancer size.

Authors:  T J Hieken; J Harrison; J Herreros; J M Velasco
Journal:  Am J Surg       Date:  2001-10       Impact factor: 2.565

2.  Variability in the interpretation of ultrasonography in patients with palpable noncalcified breast tumors.

Authors:  P Skaane; J B Olsen; E M Sager; M Abdelnoor; A Berger; G Kullmann; P A Wolff
Journal:  Acta Radiol       Date:  1999-03       Impact factor: 1.990

3.  Accuracy of MR imaging for revealing residual breast cancer in patients who have undergone neoadjuvant chemotherapy.

Authors:  Savannah C Partridge; Jessica E Gibbs; Ying Lu; Laura J Esserman; Dan Sudilovsky; Nola M Hylton
Journal:  AJR Am J Roentgenol       Date:  2002-11       Impact factor: 3.959

Review 4.  Determination of size in invasive breast carcinoma: pathologic considerations and clinical implications.

Authors:  S J Shin; M P Osborne; A Moore; M K Hayes; S A Hoda
Journal:  Am J Clin Pathol       Date:  2000-05       Impact factor: 2.493

5.  MRI phenotype is associated with response to doxorubicin and cyclophosphamide neoadjuvant chemotherapy in stage III breast cancer.

Authors:  L Esserman; E Kaplan; S Partridge; D Tripathy; H Rugo; J Park; S Hwang; H Kuerer; D Sudilovsky; Y Lu; N Hylton
Journal:  Ann Surg Oncol       Date:  2001-07       Impact factor: 5.344

6.  Correlation of three-dimensional magnetic resonance imaging with precise histopathological map concerning carcinoma extension in the breast.

Authors:  G Amano; N Ohuchi; T Ishibashi; T Ishida; M Amari; S Satomi
Journal:  Breast Cancer Res Treat       Date:  2000-03       Impact factor: 4.872

7.  MRI vs. histologic measurement of breast cancer following chemotherapy: comparison with x-ray mammography and palpation.

Authors:  P T Weatherall; G F Evans; G J Metzger; M H Saborrian; A M Leitch
Journal:  J Magn Reson Imaging       Date:  2001-06       Impact factor: 4.813

8.  Preoperative estimation of the pathological breast tumour size by physical examination, mammography and ultrasound: a prospective study on 105 invasive tumours.

Authors:  Anne M Bosch; Alfons G H Kessels; Geerard L Beets; Jan D Rupa; Dick Koster; Jos M A van Engelshoven; Maarten F von Meyenfeldt
Journal:  Eur J Radiol       Date:  2003-12       Impact factor: 3.528

9.  Accuracy of MRI in the detection of residual breast cancer after neoadjuvant chemotherapy.

Authors:  Eric L Rosen; Kimberly L Blackwell; Jay A Baker; Mary Scott Soo; Rex C Bentley; Daohai Yu; Thaddeus V Samulski; Mark W Dewhirst
Journal:  AJR Am J Roentgenol       Date:  2003-11       Impact factor: 3.959

10.  Preoperative staging of breast cancer by palpation, mammography and high-resolution ultrasound.

Authors:  H Madjar; H A Ladner; W Sauerbrei; A Oberstein; H Prömpeler; A Pfleiderer
Journal:  Ultrasound Obstet Gynecol       Date:  1993-05-01       Impact factor: 7.299

View more
  1 in total

1.  Clinicopathologic Features Predictive of Distant Metastasis in Patients Diagnosed With Invasive Breast Cancer.

Authors:  Basim Ali; Fatima Mubarik; Nida Zahid; Abida K Sattar
Journal:  JCO Glob Oncol       Date:  2020-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.